Trial reportBlood advances2022
Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial.
Lydia Scarfò, Silvia Ferrari, Anna Maria Frustaci, Monica Tani, Alessia Bari, Eloise Scarano, Maria Colia, Pamela Ranghetti, Piera Angelillo, Paola Ronchi and 3 more
Open access · goldAbstract readClinical Trial
In one paragraphTrial report in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors at 5 institutions in 1 country.
Lydia ScarfòStrategic Research Program on Chronic Lymphatic Leukemia (CLL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele and Università Vita Salute San Raffaele, Milan, Italy.
Silvia FerrariHematology and Bone Marrow Transplant Unit, Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy.ORCID 0000-0002-9917-2843 Anna Maria FrustaciDepartment of Haematology, Niguarda Cancer Center, Azienda Socio-Sanitaria Territoriale (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID 0000-0003-2587-7901 Monica TaniHematology, Santa Maria delle Croci Hospital, Ravenna, Italy.
Alessia BariDipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università di Modena e Reggio Emilia, Modena, Italy.ORCID 0000-0002-9538-2499 Eloise ScaranoStrategic Research Program on Chronic Lymphatic Leukemia (CLL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele and Università Vita Salute San Raffaele, Milan, Italy.
Maria ColiaStrategic Research Program on Chronic Lymphatic Leukemia (CLL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele and Università Vita Salute San Raffaele, Milan, Italy.
Pamela RanghettiB-cell Neoplasia Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
Piera AngelilloLymphoma Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
Paola RonchiImmunohematology and Transfusion Medicine Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy; and.
Maurilio PonzoniPathology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele and Università Vita Salute San Raffaele, Milan, Italy.
Andrés J M FerreriLymphoma Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.ORCID 0000-0001-9606-6124 Paolo GhiaStrategic Research Program on Chronic Lymphatic Leukemia (CLL), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele and Università Vita Salute San Raffaele, Milan, Italy.ORCID 0000-0003-3750-7342 Vita-Salute San Raffaele University · ITIRCCS Ospedale San Raffaele · ITOspedale Papa Giovanni XXIII · ITOspedale "Santa Maria delle Croci" di Ravenna · ITUniversity of Modena and Reggio Emilia · IT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Leukemia, Lymphocytic, Chronic, B-CellLymphomaAntibodies, Monoclonal, HumanizedAntigens, CD20HumansNeoplasm Recurrence, LocalAntibodies, Monoclonal, HumanizedAntigens, CD20ofatumumab
Identifiers
PMID35613463
PMCPMC9631708
OpenAlexW4281558983
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390